Antidiabetic agents and cardiovascular risk in type 2 diabetes

被引：0
|
作者：
Stuart W. Zarich
机构：
[1] Bridgeport Hospital,Division of Cardiovascular Medicine
来源：
Nature Reviews Endocrinology | 2009年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Currently, controversy reigns over the effects of different antidiabetic agents on cardiovascular outcomes in type 2 diabetes mellitus (T2DM). This article reviews the findings of recent cardiovascular outcome trials that assessed the safety of various glucose-lowering strategies. Multifactorial interventions to improve glycemic control, hypertension, and dyslipidemia enhance survival and reduce macrovascular events in T2DM. Insulin-sensitization regimens may be preferred in patients with T2DM who have coronary disease.
引用
收藏
页码：500 / 506
页数：6
相关论文
共 50 条
  • [1] Antidiabetic agents and cardiovascular risk in type 2 diabetes
    Zarich, Stuart W.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (09) : 500 - 506
  • [2] Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes
    Macfarlane, D. P.
    Paterson, K. R.
    Fisher, M.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (07): : 533 - 544
  • [3] Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes
    Holstein, A
    Egberts, EH
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2003, 111 (07) : 405 - 414
  • [4] Type 2 diabetes and factors of cardiovascular risk in the antidiabetic center of Abidjan
    Acka, K. F.
    Ekou, F. K.
    Akpess, A.
    Konan, P. A.
    Manouan, M.
    Kouame, S.
    Koffi, K. S.
    Kouakou, T.
    Kouakou, E.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 : S48 - S49
  • [5] Oral antidiabetic agents in type 2 diabetes
    Levetan, Claresa
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 945 - 952
  • [6] Metabolic profile and cardiovascular risk in patients with Type 2 diabetes not controlled with oral antidiabetic agents: Post-Adelante study
    Calderon, A.
    Sarasa, P.
    Barrios, V.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [7] Fracture Risk of Antidiabetic Agents in Type 2 Diabetes-A Network Meta-analysis
    Tsai, Wen Hsuan
    Kong, Siang Ke
    Tsai, Ming-Chieh
    [J]. DIABETES, 2022, 71
  • [8] IMPACT OF ANTIDIABETIC THERAPY ON THE RISK OF CARDIOVASCULAR DISEASES AND THEIR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Ametov, A. S.
    Pyanykh, O. P.
    Chernikova, N. A.
    [J]. TERAPEVTICHESKII ARKHIV, 2010, 82 (08): : 71 - 75
  • [9] Manage cardiovascular risk in patients with type 2 diabetes by using agents with proven cardiovascular benefits
    Writers, Adis Medical
    [J]. DRUGS & THERAPY PERSPECTIVES, 2020, 36 (05) : 181 - 185
  • [10] Manage cardiovascular risk in patients with type 2 diabetes by using agents with proven cardiovascular benefits
    [J]. Drugs & Therapy Perspectives, 2020, 36 : 181 - 185
12345